RPRX 241220 27.50C (RPRX241220C27500) Stock Options, News & Quotes

US OptionsDetailed Quotes

RPRX241220C27500

Watchlist

0.45
+0.19+73.08%

15min DelayTrading Nov 25 10:34 ET

0.45High0.20Low

Intraday

5D
Daily

News

BofA Securities Maintains Royalty Pharma(RPRX.US) With Buy Rating, Maintains Target Price $39
Moomoo NewsNov 19 09:31 ET · Ratings
BofA Securities Maintains Royalty Pharma(RPRX.US) With Buy Rating, Raises Target Price to $39
Moomoo NewsNov 19 07:31 ET · Ratings
Strong Buy Rating for Royalty Pharma: Robust Revenue Growth and Promising Pipeline
TipRanksNov 19 06:46 ET · Ratings
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
GlobeNewswireNov 14 16:30 ET
Royalty Pharma To Go Ex-Dividend On November 15th, 2024 With 0.21 USD Dividend Per Share
Moomoo NewsNov 13 20:00 ET
Royalty Pharma's (NASDAQ:RPRX) Solid Earnings May Rest On Weak Foundations
Simply Wall StNov 13 07:03 ET

Comments

Trytosaveabit

Nov 4 15:05

News

$Syndax Pharmaceuticals (SNDX.US)$ $Royalty Pharma (RPRX.US)$ Press Release: Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo(TM)
Dow Jones· 1 min ago

Moomoo AI

Feb 22 04:36

Unusual items boosting Royalty Pharma's profit may not recur, possibly causing a profit drop this year. The company's statutory earnings may not truly reflect its underlying earnings power. Investors should note 4 warning signs for Royalty Pharma.

There May Be Underlying Issues With The Quality Of Royalty Pharma's (NASDAQ:RPRX) Earnings

Moomoo AI

Dec 18, 2023 05:24

Significant insider share selling might worry some shareholders despite the implication of the company acting in all shareholders' interest. The overall analysis of insider transactions, however, lacks confidence.

This Insider Has Just Sold Shares In Royalty Pharma

Explore moomoo's "Insider Activity" for institutional sentiment

Alvinnnnnnngenius

Oct 19, 2023 07:01

News watch

$Royalty Pharma (RPRX.US)$

ChapmanJack

Jun 26, 2023 08:50

$Royalty Pharma (RPRX.US)$ ur past dur.. lets pop